Page last updated: 2024-12-07
1,2-dideoxyribofuranose
Description
## 1,2-Dideoxyribofuranose: A Building Block for Important Molecules
1,2-Dideoxyribofuranose is a modified sugar molecule derived from the sugar ribose. It is characterized by the absence of a hydroxyl group at the 1 and 2 positions of the ribose ring, hence the name dideoxy.
Here's a breakdown of its structure and significance:
**Structure:**
* **Base:** 1,2-Dideoxyribofuranose is a five-membered ring (furanose) derived from ribose.
* **Modifications:** It lacks the hydroxyl groups at the 1 and 2 positions, which are typically present in ribose.
* **Derivatives:** It can exist in different forms depending on the presence of other functional groups, such as the cyclic form, the linear form, and various protected forms.
**Importance in Research:**
1,2-Dideoxyribofuranose is a valuable building block in organic synthesis, especially in the following fields:
* **Nucleosides and Nucleotides:** It is a precursor to the synthesis of various nucleoside and nucleotide analogues, which are used in:
* **Antiviral therapy:** Many antiviral drugs, like AZT (zidovudine) used to treat HIV, are based on modified nucleosides containing 1,2-dideoxyribofuranose.
* **Anti-cancer therapy:** Certain nucleoside analogues are effective against various cancers due to their ability to inhibit DNA replication.
* **Carbohydrate Chemistry:** It is a model compound for studying the reactivity and properties of carbohydrates, particularly for understanding the role of hydroxyl groups in their structure and function.
* **Glycobiology:** It is used in the synthesis of complex carbohydrates and glycoconjugates, which are essential for cellular recognition and signaling.
* **Medicinal Chemistry:** Researchers are exploring its potential as a scaffold for developing new drugs with novel therapeutic properties.
**Examples of its use in research:**
* **Synthesis of AZT:** This antiviral drug contains the 1,2-dideoxyribofuranose moiety, which inhibits the replication of HIV by mimicking the natural substrate of reverse transcriptase.
* **Development of anti-cancer agents:** Researchers are developing new nucleoside analogues containing 1,2-dideoxyribofuranose that can target specific cancer pathways.
* **Study of carbohydrate-protein interactions:** The modified sugar can be used to probe the binding affinities and specificities of different carbohydrate-binding proteins.
**In conclusion, 1,2-dideoxyribofuranose plays a crucial role in various research areas, particularly in the development of novel drugs and the understanding of fundamental biological processes. Its unique structure and reactivity make it a versatile building block for creating new and impactful molecules.**
1,2-dideoxyribofuranose: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 124657 |
SCHEMBL ID | 100461 |
MeSH ID | M0127098 |
Synonyms (25)
Synonym |
1,2-drf |
1,4-anhydro-2-deoxy-d-ribitol |
(2r,3s)-2-(hydroxymethyl)oxolan-3-ol |
91547-59-0 |
AKOS006276775 |
91121-19-6 |
1,2-dideoxyribose |
2-furanmethanol, tetrahydro-3-hydroxy-, trans- |
trans-tetrahydro-3-hydroxy-2-furanmethanol |
1,2-dideoxy-beta-d-ribofuranose |
1,2-dideoxyribofuranose |
d-erythro-pentitol, 1,4-anhydro-2-deoxy-, (z,e,e,e,e)- |
1,2-dideoxy-d-ribofuranose |
SCHEMBL100461 |
NSMOSDAEGJTOIQ-CRCLSJGQSA-N |
(2r,3s)-2-(hydroxymethyl)tetrahydrofuran-3-ol |
1,4-anhydro-2-deoxy-d-erythro-pentitol |
(2r,3s)-2-hydroxymethyl-tetrahydro-furan-3-ol |
W-204062 |
DTXSID20919665 |
1,4-anhydro-2-deoxypentitol |
E71898 |
CS-0089202 |
5-methyl-2-phenyl-2h-1,2,3-triazole-4-carbonyl?chloride |
WS-03145 |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.36
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.36 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 4.66 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |